{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6846e583cca944a48e6715d3/6af1f568ed870dba3d0d2b24?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"CPHI Milan 2026: Getting Trial Medicines From A To B - Catherine Parry and Jamie Beaumont","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6846e583cca944a48e6715d3/1794241841847-bf9240fc-50b2-4581-9c2b-40fd0e679773.jpeg?height=200","description":"<p>COREX has spent 15 years moving clinical trial supplies and medicines across the globe. It doesn&#39;t manufacture anything. Its job is to make sure what sponsors make gets from A to B, and that the medicines they need are sourced, relabelled and delivered from B to C.</p><p><br></p><p>This week on Making It In Manufacturing, Ruby Collier sat down with Jamie Beaumont, Global Head of Clinical Trial Sourcing, and Catherine Parry, Business Development Director at COREX, at CPHI Milan 2026, where ARTO was the official podcast partner.</p><p><br></p><p>In this episode, Jamie and Catherine cover:</p><p><br></p><p>(01:05) What COREX does: clinical trial logistics, named patient programmes, and sourcing the commercial medicines sponsors and CROs need for their studies.</p><p><br></p><p>(02:21) Where COREX sits in the supply chain, alongside CROs, CDMOs, biotechs and sponsors.</p><p><br></p><p>(03:01) Why they both joined COREX this year: its reputation for customer service, and the push into international and emerging markets.</p><p><br></p><p>(05:08) What happens when a sponsor needs a comparator, from central sourcing in bulk to buying in a single country for a single patient.</p><p><br></p><p>(06:26) When sponsors realise they have a supply problem (probably too late), and why the conversation should start earlier.</p><p><br></p><p>(07:49) What&#39;s driving COREX&#39;s growth after 15 years: more services, in more countries.</p><p><br></p><p>(08:58) How COREX competes with the giant logistics players: reliability, supply chain security, knowledge and the personal touch.</p><p><br></p><p>(10:33) The next three to five years: busier trials, more flexible supply, less wastage, and more focus on recruiting and keeping patients.</p><p><br></p><p>(13:32) One piece of advice for a sponsor starting a global trial tomorrow.</p><p><br></p><p>Listen to the full episode to hear why, for COREX, there&#39;s always a patient at the end of the service.</p><p><br></p><p>Register your interest for CPHI Frankfurt 2027 here: https://www.cphi.com/europe/register-attend/?utm_source=partner&amp;utm_medium=referral&amp;utm_campaign=hln27cpw-cl-arto</p><p><br></p><p>Follow ARTO</p><p><br></p><p>LinkedIn: https://www.linkedin.com/company/artotalent/</p><p>Spotify: https://open.spotify.com/show/1cSZVJ63yXJ3kqnVORyTbw</p><p>Instagram: https://www.instagram.com/arto.talent</p><p>TikTok: https://www.tiktok.com/@artotalent</p><p>Apple Podcasts: https://podcasts.apple.com/gb/podcast/making-it-in-manufacturing/id1819731245</p><p>Website: https://arto-talent.com/</p><p>Youtube: https://www.youtube.com/@artotalent</p><p><br></p><p>Catherine Parry</p><p>LinkedIn: https://www.linkedin.com/in/catherine-parry-55107a4b/</p><p><br></p><p>Jamie Beaumont</p><p>LinkedIn: https://www.linkedin.com/in/jamie-beaumont-2b63b9250/</p><p><br></p><p>Ruby Collier</p><p>LinkedIn: https://www.linkedin.com/in/rubycollier/</p><p><br></p><p>Timestamps:</p><p><br></p><p>00:00 Introduction</p><p>01:05 What COREX does</p><p>02:21 Where COREX sits in the supply chain</p><p>03:01 Why they joined COREX</p><p>05:08 Inside comparator sourcing</p><p>06:26 Why sponsors call too late</p><p>07:49 What&#39;s driving the growth</p><p>08:58 Competing with the giants</p><p>10:33 The next three to five years</p><p>13:32 One piece of advice</p><p><br></p><p>#MakingItInManufacturing #ARTOTalent #CPHI #CPHIMilan #ClinicalTrials #ClinicalSupply #ComparatorSourcing #PharmaLogistics</p>","author_name":"ARTO Talent"}